ArticleEMBO molecular medicine2025

A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors.

Yuncheng Bei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.